首页 > 市场调查报告书 > 製药

骨疾病

市场调查报告书

商品编码

1629613

骨形成蛋白市场：按类型、按应用、按最终用户、按地区

Bone Morphogenetic Protein Market, By Type (Recombinant Bone Morphogenetic Proteins, Synthetic Bone Morphogenetic Proteins, and Natural Bone Morphogenetic Proteins), By Application, By End User, By Geography

出版日期: 2024年12月04日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球骨形成蛋白市场规模为3.423亿美元，预计2031年将达4.445亿美元，2024年至2031年复合年增长率为3.8%。

报告范围		报告详情
基准年	2023年	2024年市场规模	3.423 亿美元
实际资料	2019-2023	预测期	2024-2031
预测 2024-2031 年复合年增长率：	3.80%	2031年价值预测	4.445 亿美元

图：2024 年各地区骨形成蛋白市场占有率(%)

由于整形外科疾病的流行和脊椎融合手术数量的增加，过去几年骨形成蛋白的全球市场出现了显着增长。骨形成蛋白(BMP) 属于转化生长因子-B (TGF-B) 超家族。 BMP 在骨形成、控製成骨细胞分化和基材矿化中发挥重要作用。 BMP 被核准用于脊椎融合手术和长骨骨折的癒合。调查 BMP 功效和安全性的各种临床和临床前研究已证明其诱导新骨形成的潜力。随着人们对骨形成蛋白的好处和这些新型生技药品的商业可用性的认识不断提高，骨形成蛋白市场预计将在预测期内出现显着增长。

市场动态：

全球骨骨形成蛋白骨形成蛋白市场的主要成长动力是老年人口的增加以及相关的整形外科手术和疾病的增加、脊椎疾病盛行率的增加、替代治疗方法的缺乏，其中包括商业性可用性和采用。然而，使用 BMP 的安全问题和高成本的缺点预计将限制市场成长。持续的研发重点是开发更安全、更便宜的 BMP 配方，预计在未来几年为市场相关人员创造利润丰厚的机会。

本研究的主要特点

本报告详细分析了全球骨形成蛋白市场，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。

它还阐明了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球骨形成蛋白市场的主要企业。

本研究涵盖的主要企业包括 Medtronic、Stryker、DePuy Synthes、NuVasive、Orthofix Holdings、Smith & Nephew、Thermo Fisher Scientific、R&D Systems、Ember Therapeutics、Sigma Aldrich、Cellumed Co. Ltd.、ProSpec 和 Wright Medical Group。和Bioventus。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

骨形成蛋白的全球市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。

透过用于分析全球骨形成蛋白市场的各种策略矩阵，将促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 342.3 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	3.80%	2031 Value Projection:	US$ 444.5 Mn

Global bone morphogenetic protein market has been witnessing notable growth in the past few years, owing to increasing prevalence of orthopedic diseases and rising number of spinal fusion surgeries. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-B (TGF-B) superfamily. BMPs play an important role in bone formation and regulate osteoblast differentiation and matrix mineralization. They have been approved for use in spinal fusion and long bone fracture healing. Various clinical and preclinical studies investigating their effectiveness and safety have demonstrated their potential to induce new bone formation. With rising awareness regarding their benefits and commercial availability of these novel biologics, the bone morphogenetic protein market is expected to experience significant growth over the forecast period.

Market Dynamics:

The primary growth drivers for the global bone morphogenetic protein market include rising geriatric population and subsequent increase in orthopedic surgeries and diseases, increasing prevalence of spinal disorders, lack of alternative treatment options, and commercial availability and adoption of bone morphogenetic proteins. However, shortcomings related to safety concerns over BMP use and high costs are expected to restrain the market growth. Ongoing research and development activities focusing on developing safer and affordable BMP formulations is expected to create lucrative opportunities for market players over the next few years.

Key Features of the Study:

This report provides in-depth analysis of the global bone morphogenetic protein market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global bone morphogenetic protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Stryker, DePuy Synthes, NuVasive, Orthofix Holdings, Smith & Nephew, Thermo Fisher Scientific, R&D Systems, Ember Therapeutics, Sigma Aldrich Co., Cellumed Co. Ltd., ProSpec, Wright Medical Group N.V., Amedica Corporation, and Bioventus

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global bone morphogenetic protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone morphogenetic protein market

Market Segmentation

By Type Insights (Revenue, USD Mn, 2019 - 2031)
- Recombinant Bone Morphogenetic Proteins (rhBMPs)
- Synthetic Bone Morphogenetic Proteins
- Natural Bone Morphogenetic Proteins
By Application Insights (Revenue, USD Mn, 2019 - 2031)
- Orthopedic Surgeries
- Dental Surgeries
- Spinal Surgeries
- Craniofacial Surgeries
- Other Applications
By End User Insights (Revenue, USD Mn, 2019 - 2031)
- Hospitals
- Ambulatory Surgical Centers
- Research Institutions
- Others
Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic
- Stryker
- DePuy Synthes
- NuVasive
- Orthofix Holdings
- Smith & Nephew
- Thermo Fisher Scientific
- R&D Systems
- Ember Therapeutics
- Sigma Aldrich Co.
- Cellumed Co. Ltd.
- ProSpec
- Wright Medical Group N.V.
- Amedica Corporation
- Bioventus

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Bone Morphogenetic Protein Market, By Type
- Global Bone Morphogenetic Protein Market, By Application
- Global Bone Morphogenetic Protein Market, By End User
- Global Bone Morphogenetic Protein Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Bone Morphogenetic Protein Market, By Type, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Recombinant Bone Morphogenetic Proteins (rhBMPs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Synthetic Bone Morphogenetic Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Natural Bone Morphogenetic Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Bone Morphogenetic Protein Market, By Application, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Orthopedic Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Dental Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Spinal Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Craniofacial Surgeries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Bone Morphogenetic Protein Market, By End User, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Bone Morphogenetic Protein Market, By Region, 2019 - 2031, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country 2019 - 2031, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DePuy Synthes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NuVasive
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Orthofix Holdings
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Smith & Nephew
Thermo Fisher Scientific
R&D Systems
Ember Therapeutics
Sigma Aldrich Co.
Cellumed Co. Ltd.
ProSpec
Wright Medical Group N.V.
Amedica Corporation
Bioventus

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

骨形成蛋白市场：按类型、按应用、按最终用户、按地区